Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > SONA ROCKET example for VXL

<< Previous

Bullboard Posts

Next >>

Comment by Valuehunter72on Jul 04, 2020 12:36pm

115 Views

Post# 31224112

RE:RE:RE:RE:RE:RE:RE:RE:SONA ROCKET example for VXL

I never saw any evidence that Vaxil was ever at the whitehouse.....sorry. I watched the live stream video back in late February early March when it occurred. There was 10 to 12 companies represented at the table....BIG names like Pfizer.....sorry Vaxil was never there. That was fake news.

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources